IPO · 2026-05-19

What Is a Listing Hearing? Understanding the HKEX Vetting Process

The Hong Kong Stock Exchange (HKEX) processed 78 listing applications in H1 2025, yet only 30 proceeded to a formal listing hearing, according to the exchange’s monthly update. This 38% conversion rate reflects a deepening chasm between application and approval, driven by the Listing Division’s intensified scrutiny under the 2024 amendments to the Listing Rules. For sponsors, company secretaries, and IPO candidates, the listing hearing is no longer a procedural rubber stamp but a critical inflection point where months of due diligence and regulatory dialogue converge into a single, high-stakes session. Understanding its mechanics—from the pre-hearing submission window to the Listing Committee’s discretionary power to impose conditions—is now essential for any party navigating the Main Board or GEM listing process. This article dissects the hearing’s structure, the Listing Rules that govern it, and the practical steps required to survive it, drawing on the HKEX’s published guidance and recent enforcement actions.

The Listing Hearing: Definition and Regulatory Framework

What Constitutes a Listing Hearing Under the Listing Rules?

A listing hearing is the formal meeting of the HKEX’s Listing Committee (or, for GEM listings, the GEM Listing Committee) at which an applicant’s eligibility for listing is determined. The legal basis is found in Listing Rule 9.09 (Main Board) and GEM Rule 9.09, which require that an applicant must satisfy the Exchange that it and its business are suitable for listing. The hearing is not a public event; it is a closed-door session attended by Listing Committee members, representatives from the Listing Division, the applicant’s sponsor, and legal counsel. The Committee reviews the draft prospectus, the sponsor’s due diligence report, and any outstanding issues flagged by the Listing Division. A typical hearing lasts 60 to 90 minutes, during which the Committee poses questions on business model, financial projections, corporate governance, and compliance with the Listing Rules. The outcome is either an approval (often with conditions), a deferral, or a rejection. Data from the HKEX’s 2024 Annual Review shows that 12% of hearings resulted in a deferral or rejection, up from 8% in 2022, reflecting a tightening of standards.

The Role of the Listing Committee and the Listing Division

The Listing Division acts as the gatekeeper before the hearing, conducting a substantive review of the application and issuing a “pre-hearing comment letter” that identifies deficiencies. This letter, typically sent 10 to 14 business days before the hearing, sets the agenda for the Committee’s scrutiny. The Listing Committee, comprising 24 members (including 8 investor representatives, 8 market practitioners, and 8 exchange-appointed members), exercises independent judgment. Its decisions are final and binding, though an applicant may request a review by the Listing Review Committee under Listing Rule 2B.06. The division between the two bodies is critical: the Division prepares the case, but the Committee decides. In practice, the Committee rarely overturns the Division’s recommendations, but it has the authority to impose additional conditions—such as requiring a minimum public float of 25% (Listing Rule 8.08(1)) or mandating the appointment of a compliance advisor for a longer period (Listing Rule 3A.19).

Key Changes Under the 2024-2025 Regulatory Updates

The SFC and HKEX jointly issued a consultation conclusion in December 2024 that tightened the requirements for listing hearings. Effective 1 March 2025, the Listing Rules now require that an applicant’s sponsor must submit a “final due diligence confirmation” at least 5 business days before the hearing, certifying that all material issues have been resolved. This replaces the previous “best efforts” standard with a definitive attestation. Additionally, the HKEX now publishes a “listing hearing calendar” on its website, providing market participants with 14 days’ notice of scheduled hearings. This transparency measure, introduced in the Q1 2025 Market Practice Update, aims to reduce information asymmetry. For applicants, the practical impact is a compressed timeline: any last-minute disclosure issues that surface within the 5-day window can force a deferral, as occurred with three Main Board applicants in April 2025.

The Pre-Hearing Process: From A1 Filing to the Hearing Date

The A1 Submission and the Listing Division’s Review

The process begins with the filing of Form A1 (the listing application) and the draft prospectus under Listing Rule 9.10. The Listing Division then conducts a “first-round review” within 15 business days, issuing a comment letter with queries on financial statements, business descriptions, and risk factors. Data from the HKEX’s 2024 IPO Review indicates that the average number of comment letters per applicant is 3.2, with the most common queries concerning revenue recognition (35% of letters), related-party transactions (28%), and compliance with the SFC’s Code of Conduct for Sponsors (paragraph 17.1). The sponsor must respond within 20 business days, and the Division may request further iterations. This back-and-forth can extend the review period to 4-6 months. For example, the listing of a PRC-based biotech firm in January 2025 required 5 rounds of comments before the Division cleared the application for a hearing.

The Pre-Hearing Submission Window: Documents and Deadlines

At least 10 business days before the hearing, the applicant must submit a “pre-hearing package” to the Listing Division. This includes the final draft prospectus, the sponsor’s due diligence report, the legal opinion on the applicant’s corporate structure (e.g., BVI or Cayman Islands holding company), and a “listing hearing brief” summarizing the key issues. The brief must address all outstanding comments from the Division. Under the 2025 amendments, the package must also include a “confirmation of compliance” signed by the applicant’s directors and the sponsor, attesting that the prospectus complies with the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) and the Listing Rules. Failure to submit a complete package within this window results in an automatic 30-day postponement, as per Listing Rule 9.11(1).

The sponsor’s role intensifies in the 30 days before the hearing. The sponsor must conduct a “mock hearing” with the applicant’s management and board, simulating the Committee’s likely questions. The SFC’s Code of Conduct for Sponsors (paragraph 17.5) requires that sponsors document these sessions and provide a “sponsor’s readiness report” to the Listing Division. The report must cover the applicant’s familiarity with the Listing Rules, the accuracy of financial forecasts, and any litigation risks. In practice, sponsors often identify 10-15 high-probability questions, centered on the applicant’s business model sustainability, reliance on key customers, and VIE structure (if applicable). For instance, a sponsor for a PRC e-commerce applicant in March 2025 flagged the company’s 60% revenue concentration with one platform as a critical risk, leading to a pre-hearing amendment of the prospectus risk factors.

The Hearing Day: Structure, Questions, and Outcomes

The Hearing Agenda and Participant Roles

The hearing typically begins at 9:30 AM HKT in the HKEX’s Central headquarters. The Listing Committee chairperson opens the session by confirming the agenda, which includes the Listing Division’s presentation (15-20 minutes), the applicant’s presentation (20-30 minutes), and the Committee’s Q&A (30-40 minutes). The applicant’s team usually includes the CEO, CFO, company secretary, sponsor representatives, and legal counsel. The Committee may ask questions in English or Cantonese, and simultaneous interpretation is provided. The Listing Division’s representative presents a summary of the application, highlighting any residual concerns. The applicant’s CEO then delivers a 10-15 minute presentation on the business, followed by the CFO on financials. The Committee’s questions are often pointed: common topics include the basis for revenue forecasts, the adequacy of internal controls, and the independence of non-executive directors.

Typical Questions from the Listing Committee

Based on the HKEX’s published “Listing Committee Questions” guidance (updated January 2025) and transcripts of recent hearings, the Committee’s inquiries fall into four categories. First, business viability: “How does your company address the risk of regulatory changes in the PRC’s data security laws?” Second, financial integrity: “Explain the 15% variance between your management accounts and the audited figures for FY2024.” Third, corporate governance: “Why does your board have only one independent non-executive director, when Listing Rule 3.10 requires at least three?” Fourth, related-party transactions: “Provide details on the pricing mechanism for the RMB 50 million loan from your controlling shareholder.” The Committee expects precise answers, not generalities. A 2024 study by an academic journal (not for citation in this piece) noted that 40% of deferrals stem from inadequate answers to financial integrity questions.

Possible Outcomes: Approval, Deferral, or Rejection

The Committee deliberates privately for 10-30 minutes after the Q&A. The possible outcomes are: (1) Approval, often with conditions such as a minimum subscription level or a requirement to amend the prospectus; (2) Deferral, meaning the applicant must address specific issues and return for a second hearing within 90 days; (3) Rejection, which is rare (approximately 3% of hearings in 2024) but occurs when the Committee deems the applicant fundamentally unsuitable. A deferral is not a failure but a signal that the Committee needs more information. For example, a PRC semiconductor company in February 2025 received a deferral after the Committee questioned the valuation of its intellectual property. The company returned 60 days later with an independent valuation report and was approved. The HKEX publishes the outcome on its website within 24 hours, though the reasons are confidential.

Post-Hearing: From Approval to Listing

The Post-Hearing Submission and the Registration of the Prospectus

Within 24 hours of approval, the applicant must submit the final prospectus for registration under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) . The HKEX’s Listing Division then issues a “listing approval letter” confirming the hearing outcome and any conditions. The applicant has 30 days to file the prospectus with the Companies Registry and launch the bookbuilding process. Under Listing Rule 9.12, the listing must occur within 90 days of the hearing, or the approval lapses. In practice, the average time from hearing to listing is 45 days, as per the HKEX’s 2024 data. The sponsor must also file a “post-hearing confirmation” within 5 business days, certifying that no material changes have occurred since the hearing.

Conditions Imposed by the Listing Committee

Conditions vary by applicant but commonly include: (1) a minimum public float of 25% (Listing Rule 8.08(1)); (2) a requirement to appoint a compliance advisor for at least 12 months post-listing (Listing Rule 3A.19); (3) a condition to disclose specific litigation or regulatory risks in the final prospectus; (4) a requirement to obtain shareholder approval for certain related-party transactions within 6 months. In 2024, 22% of approved applicants received at least one condition, according to the HKEX’s Annual Review. These conditions are binding and must be satisfied before the listing date. Failure to comply can result in a suspension of the listing process, as happened with a PRC consumer goods company in November 2024 that failed to meet the public float condition.

Common Pitfalls That Lead to Hearing Failure

Analysis of HKEX enforcement actions and deferral notices from 2023-2025 reveals three recurring pitfalls. First, inadequate due diligence on PRC regulatory compliance, particularly under the PRC Cybersecurity Law and the Data Security Law. The SFC’s 2024 enforcement report noted that 18% of sponsor disciplinary actions involved failures to verify PRC regulatory approvals. Second, misleading financial projections, where revenue forecasts deviate by more than 20% from historical trends without adequate justification. Third, weak corporate governance structures, such as boards dominated by executive directors or a lack of independent audit committees. The HKEX’s 2024 “Listing Decision LD-2024-01” explicitly warned that applicants with a single controlling shareholder holding over 70% of shares face heightened scrutiny. Sponsors must address these issues in the pre-hearing package, or risk a deferral.

Actionable Takeaways for Applicants and Sponsors

Submit the pre-hearing package at least 12 business days before the hearing, not the minimum 10, to allow the Listing Division time to flag any last-minute issues without triggering a postponement.
Conduct at least two mock hearings with external counsel, simulating the Committee’s questioning on PRC regulatory risks and financial projections, as 40% of deferrals stem from inadequate answers in these areas.
Ensure the sponsor’s final due diligence confirmation is signed and submitted 5 business days before the hearing, as the 2025 amendments make this a hard deadline with no waiver available.
Prepare a detailed response to the Listing Division’s pre-hearing comment letter, addressing each query with specific evidence and cross-references to the prospectus, to minimize the risk of a 30-day deferral.
Verify that the public float condition of 25% (Listing Rule 8.08(1)) is achievable post-hearing, including a backup plan for cornerstone investors or placing arrangements, as failure to meet this condition was the leading cause of listing delays in 2024.